If it runs back up , its just another example of irrational exuberance in the markets. It doubled on information from Phase 1 results, Phase 111 results maybe, not Phase 1. They are years from getting FDA approval and a product on the market. They are burning through approximately 65 million a year and that will increase as they proceed with new trials.
This thing is way higher than it should be, I expect the price to work its way down, but that's just my opinion. We will see.